PDF(Pubmed)
Abstract：
BACKGROUND: Treatment adherence is a primary key in controlling diabetes disease. The study aims to determine the prevalence of treatment adherence in type 2 diabetes mellitus (T2DM) patients, investigate the potential influence of adherence on elevated blood glucose levels, and identify the key factors which play a role in non-adherence to the prescribed drugs.
METHODS: A cross-sectional study method was utilized to collect data from all T2DM patients at the Diabetic and Endocrine Centre and Shar Hospital in Sulaymaniyah city in the Kurdistan region of Iraq from February 2022 to April 2022. The data collection was performed through a structured questionnaire. The prevalence of drug adherence was assessed using the Morisky Medication-Taking Adherence Scale (4-item), and the glycated hemoglobin test (A1C) was used to determine the blood glucose level.
RESULTS: A total of 300 participants were studied, and more than half of them (192; 64%) revealed that they did not adhere to their anti-diabetic medications. Non-adherence was significantly associated with higher A1C. Several barriers to non-adherence were identified as multiple medications, feeling the dose given is high, lack of finance, and side effects by 209 (70%), 116 (39%), 113 (38%), and 103 (34%), respectively.
CONCLUSIONS: The current study\'s result revealed that most T2DM patients have no adherence to their medication. This non-adherence is significantly linked to higher A1C levels, emphasizing the critical role of medication compliance in managing diabetes effectively. The study also sheds light on the multiple barriers such as taking multiple prescriptions, the perception that the dose is excessive, lack of finances, and experiencing side effects, which contribute to non-adherence among diabetes patients. These findings underscore the need for healthcare providers to address these barriers and develop tailored strategies to enhance medication adherence among individuals with diabetes.
METHODS: A cross-sectional study method was utilized to collect data from all T2DM patients at the Diabetic and Endocrine Centre and Shar Hospital in Sulaymaniyah city in the Kurdistan region of Iraq from February 2022 to April 2022. The data collection was performed through a structured questionnaire. The prevalence of drug adherence was assessed using the Morisky Medication-Taking Adherence Scale (4-item), and the glycated hemoglobin test (A1C) was used to determine the blood glucose level.
RESULTS: A total of 300 participants were studied, and more than half of them (192; 64%) revealed that they did not adhere to their anti-diabetic medications. Non-adherence was significantly associated with higher A1C. Several barriers to non-adherence were identified as multiple medications, feeling the dose given is high, lack of finance, and side effects by 209 (70%), 116 (39%), 113 (38%), and 103 (34%), respectively.
CONCLUSIONS: The current study\'s result revealed that most T2DM patients have no adherence to their medication. This non-adherence is significantly linked to higher A1C levels, emphasizing the critical role of medication compliance in managing diabetes effectively. The study also sheds light on the multiple barriers such as taking multiple prescriptions, the perception that the dose is excessive, lack of finances, and experiencing side effects, which contribute to non-adherence among diabetes patients. These findings underscore the need for healthcare providers to address these barriers and develop tailored strategies to enhance medication adherence among individuals with diabetes.
摘要：
背景：治疗依从性是控制糖尿病疾病的主要关键。该研究旨在确定2型糖尿病（T2DM）患者治疗依从性的患病率。研究依从性对血糖水平升高的潜在影响，并确定在不遵守处方药中起作用的关键因素。
方法：采用横断面研究方法，从2022年2月至2022年4月在伊拉克库尔德斯坦地区苏莱曼尼亚市的糖尿病和内分泌中心和沙尔医院收集所有T2DM患者的数据。数据收集是通过结构化问卷进行的。使用Morisky服药依从性量表（4项）评估药物依从性的患病率，糖化血红蛋白测试（A1C）用于确定血糖水平。
结果：共研究了300名参与者，超过一半的人（192;64％）表示他们没有坚持使用抗糖尿病药物。非依从性与较高的A1C显著相关。不遵守的几个障碍被确定为多种药物，感觉给的剂量很高，缺乏资金,和副作用209（70％），116（39%），113（38%），103（34%），分别。
结论：本研究结果显示，大多数T2DM患者不坚持用药。这种不坚持与较高的A1C水平显着相关，强调药物依从性在有效管理糖尿病中的关键作用。该研究还揭示了多种障碍，例如服用多种处方，认为剂量过大，缺乏资金，并经历副作用，这有助于糖尿病患者的不依从性。这些发现强调了医疗保健提供者需要解决这些障碍，并制定量身定制的策略来提高糖尿病患者的药物依从性。
方法：采用横断面研究方法，从2022年2月至2022年4月在伊拉克库尔德斯坦地区苏莱曼尼亚市的糖尿病和内分泌中心和沙尔医院收集所有T2DM患者的数据。数据收集是通过结构化问卷进行的。使用Morisky服药依从性量表（4项）评估药物依从性的患病率，糖化血红蛋白测试（A1C）用于确定血糖水平。
结果：共研究了300名参与者，超过一半的人（192;64％）表示他们没有坚持使用抗糖尿病药物。非依从性与较高的A1C显著相关。不遵守的几个障碍被确定为多种药物，感觉给的剂量很高，缺乏资金,和副作用209（70％），116（39%），113（38%），103（34%），分别。
结论：本研究结果显示，大多数T2DM患者不坚持用药。这种不坚持与较高的A1C水平显着相关，强调药物依从性在有效管理糖尿病中的关键作用。该研究还揭示了多种障碍，例如服用多种处方，认为剂量过大，缺乏资金，并经历副作用，这有助于糖尿病患者的不依从性。这些发现强调了医疗保健提供者需要解决这些障碍，并制定量身定制的策略来提高糖尿病患者的药物依从性。
